This was a double-blind , randomized comparison of isosorbide-5-mononitrate ( IS-5-MN ) , 60 mg given orally , once daily for 11 months to patients ( n = 47 ) with left ventricular ( LV ) dysfunction following acute myocardial infarction ( AMI ) .
